Clinical trial
Personalized Atrial Fibrillation Ablation Guided by Non-Invasive Global Mapping - the CURE-AF Pilot Study
NCT07320560 is registered in ClinicalTrials.gov with German Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Atrial Fibrillation Ablation Guided by Non-Invasive Global Mapping - the CURE-AF Pilot Study
- Lead sponsor
- German Heart Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 15, 2026
- Completion date
- December 31, 2027
- Enrollment
- 45 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af)